Delta-8 vs Delta-10 THC: Chemistry, Effects, Evidence and the 2026 Law

Delta-8 and delta-10 THC are isomers of delta-9 THC: same atoms, with one double bond in a different place. Delta-8 is intoxicating but less potent than delta-9 in controlled human trials. Delta-10 is almost entirely made by chemical conversion, has no controlled human trials, and lab data on how strongly it acts on the CB1 receptor conflict. Both are being pushed out of the federal hemp definition in late 2026.

Most pages ranking for this comparison describe delta-10 as “energising” and delta-8 as “relaxing”, then move on to where to buy. That framing comes from marketing and user anecdote, not from studies. Below we set out what each compound is, what has actually been measured, the safety signals, and how the new federal rules change the picture.

If you are new to the parent compound, our comparison of delta-8 and delta-9 THC covers the baseline.

At a glance

Property	Delta-8 THC	Delta-10 THC
What it is	Isomer of delta-9 THC, double bond at carbon 8	Isomer of delta-9 THC, double bond at carbon 10
Natural occurrence	Present in cannabis in small amounts	Described by forensic chemists as an unnatural isomer6
How products are made	Acid-catalysed conversion of hemp CBD	Further chemical conversion; exists as cis and trans forms4
CB1 receptor activity	Partial agonist, weaker affinity than delta-91	Conflicting lab data: weak agonist or antagonist4,5
Controlled human trials	Yes, oral and vaped (2025)2,3	None found
Intoxicating?	Yes, dose-dependent	Users report effects; not measured in trials
Drug test	Metabolites trigger standard urine screens9	Carboxylic acid metabolites also cross-react9
US federal status	Loses hemp status by 11 December 2026	12 November or 11 December 2026, depending on FDA classification
UK status	Class B controlled drug	Class B controlled drug

What delta-8 and delta-10 THC actually are

THC isomers share one formula and differ in where a single carbon-carbon double bond sits in the ring system. In delta-9 it sits at the ninth carbon, in delta-8 at the eighth and in delta-10 at the tenth. Small shifts like this change how well the molecule fits the CB1 receptor, the main target behind cannabis intoxication. Our glossary entries on delta-8 THC and delta-10 THC cover the basics.

Delta-8 occurs in the cannabis plant, but only in trace amounts. Almost all delta-8 on the market is made from hemp-derived CBD using acid and heat, a process described in our entry on hemp isomerisation. Delta-10 comes from further conversion steps and exists in at least two forms, cis and trans, which behave differently in lab tests.⁴

One reaction separates the two in practice. Converting CBD reliably gives mostly delta-8; getting delta-10 requires more aggressive chemistry. More steps mean more chances for unintended by-products, and analysts have found several unnatural THC isomers, including delta-10, in vaping liquids examined after the 2019 lung injury outbreak.⁶

How they act on the body: receptor and animal data

Delta-8 has the stronger evidence base. A 2022 review of decades of studies found its pharmacology closely resembles delta-9: it is a partial agonist at the CB1 receptor, produces cannabis-like effects in animals and humans, and its lower potency is best explained by weaker receptor affinity.¹

Delta-10 is a puzzle. In one in vitro study, both delta-10 isomers bound CB1 more weakly than delta-9, showed no agonist activity at concentrations up to 10 micromolar, and instead blocked a reference agonist.⁴ That would suggest little THC-like intoxication. A 2024 mouse study, however, found that one delta-10 isomer partly substituted for delta-9 in a drug discrimination test, a model of subjective effects, while delta-8 substituted fully.⁵

These results are not necessarily contradictory. They used different isomers, assays and species, and neither involved people. What they show is that “delta-10 is a milder delta-8” is not an established fact. It is a hypothesis resting on thin, preclinical data.

Effects in practice: what trials show and what users report

In 2025, US researchers published two double-blind crossover trials comparing delta-8 with delta-9 in healthy adults. In the oral trial (19 people), 20 mg of delta-8 produced lower ratings of drug effect, less impairment and a smaller heart-rate rise than 20 mg of delta-9. But 40 mg of delta-8 was indistinguishable from 20 mg of delta-9, and drug liking was similar across doses.²

The vaped trial (20 people) found that delta-8 doses from 10 to 40 mg produced psychoactive effects broadly comparable to 20 mg of delta-9, with people taking larger puffs at lower doses.³ The practical point: delta-8 is less potent per milligram, but people can and do take more of it.

There are no comparable trials of delta-10. Claims that it is clear-headed, uplifting or “sativa-like” come from sellers and user reports. Those reports may be real experiences, but they cannot separate the compound from expectation, dose, the other cannabinoids in the product, or the unlisted by-products that conversion can leave behind.

How strong is the evidence?

• Delta-8: small but well-designed human trials, a large preclinical literature, and surveillance data. Moderate for acute effects; weak for long-term use.
• Delta-10: a handful of lab and animal studies and no controlled human data. Very weak.

Safety, side effects and drug testing

An analysis of US poison centre data found 5,022 cases involving delta-8, delta-10 or THC-O acetate as the main substance in 2021 and 2022. Delta-8 accounted for 98.1% of them, which partly reflects market share. Children under six made up 30.1% of cases, almost all through swallowing products, and 38.4% of all cases had a serious medical outcome.⁷ The most common effects were mild central nervous system depression, a fast heart rate and agitation.

Product quality is a separate risk. When chemists analysed 27 delta-8 vape products from 10 brands, none carried accurate delta-8 labelling, 11 contained unlabelled cutting agents, and all contained reaction by-products and heavy metals.⁸ Delta-10 products, which need more conversion steps, have not been studied as closely, which is not reassurance.

Drug testing is where many people are caught out. A laboratory study of six common urine immunoassays found they cross-reacted with delta-8 metabolites and with delta-10 carboxylic acid metabolites, with sensitivity varying by kit and cutoff.⁹ In plain terms, either compound can produce a positive cannabis screen. Confirmation testing can tell isomers apart, but most workplace policies treat any THC use the same way.

Both compounds impair coordination and reaction time in the same way cannabis can, so do not drive after use. Anyone taking prescription medicines, or who is pregnant or breastfeeding, should speak to a clinician first.

Legal status in September 2026: a moving target

This is the section most likely to be out of date by the time you read it, so the dates matter. Until now, both compounds were sold under the 2018 Farm Bill definition of hemp, which only limited delta-9 THC to 0.3% by dry weight. That definition is being replaced.

The federal redefinition

Section 781 of Public Law 119-37, signed on 12 November 2025, rewrites the definition of hemp from 12 November 2026.¹⁰ Under the new text:

• Hemp is measured by total THC (including THCA), not delta-9 alone.
• Final products are excluded if they contain cannabinoids “not capable of being naturally produced” by the plant, or naturally occurring cannabinoids that were synthesised or manufactured outside the plant.
• Final products are also excluded if they contain more than 0.4 mg per container of total THC combined with other cannabinoids that have, or are marketed to have, similar effects.

In September 2026 Congress passed a one-month delay (H.R. 6500, section 2019). Until 11 December 2026, only the exclusion for cannabinoids not capable of being naturally produced applies; everything else, including the total THC test and the 0.4 mg cap, starts on 11 December.¹¹ A product that falls outside the hemp definition loses the hemp exemption from the Controlled Substances Act.

Which date applies to which compound

Delta-8 occurs naturally in small amounts, so it should fall under the 11 December provisions, and commercial delta-8 made from CBD is caught by the “manufactured outside the plant” wording from that date. Delta-10 is less clear. Forensic chemists have described it as an unnatural THC isomer,⁶ which would put it in the 12 November category. The law told the FDA to publish lists of naturally occurring and THC-like cannabinoids within 90 days; the Congressional Research Service reported in August 2026 that these had not appeared.¹² Either way, a typical delta-8 or delta-10 gummy or vape holds far more than 0.4 mg per container, so neither product type survives past 11 December as hemp.

Bills to delay the change to 2028, repeal it or replace it with a regulatory framework are in committee, with no votes scheduled at the time of writing. Many states already restricted these products before the federal change; see our state-by-state delta-8 guide.

UK and Canada: in the UK, both are tetrahydro derivatives of cannabinol and fall under Class B of the Misuse of Drugs Act 1971. In Canada, the Cannabis Act covers phytocannabinoids and any identical substance however it is made, so these are cannabis products sold only through licensed channels.

What to check on a label or certificate of analysis

Until the federal change takes effect, and in states where these products remain on sale, the certificate of analysis (COA) is the only independent check on what is in the package. Our guide to reading a hemp COA explains the layout. For these two compounds specifically, look for:

• A full isomer panel. The COA should report delta-8, delta-9 and delta-10 separately. A panel that only lists “total cannabinoids” hides the detail that matters.
• Delta-9 and total THC. Conversion can leave delta-9 behind as a by-product,⁸ so a product sold as delta-8 or delta-10 may contain more delta-9 than you expect.
• Residual solvents and heavy metals. These are the contaminants most associated with conversion chemistry and vape hardware.
• Batch match and lab accreditation. The batch number on the COA should match the package, and the lab should be ISO/IEC 17025 accredited.
• Milligrams per serving and per container. From 11 December 2026 the federal hemp cap is 0.4 mg of total THC and similar cannabinoids per container.

A product labelled “delta-10” that shows mostly delta-8 or delta-9 on its COA is common enough that it is worth checking before anything else.

Frequently asked questions

Is delta-10 stronger than delta-8?

There is no human evidence that it is. Delta-8 has been compared with delta-9 in controlled trials and is less potent per milligram. Delta-10 has not been tested in people, and lab studies disagree on whether it activates the CB1 receptor at all.^4,5 Most sources describe delta-10 as milder, but that rests on user reports rather than measurement.

Will delta-8 or delta-10 show up on a drug test?

Very likely. A study of six widely used urine immunoassays found they cross-reacted with delta-8 metabolites and with delta-10 carboxylic acid metabolites.⁹ A positive screen may be confirmed by more specific testing, but many employers treat any THC isomer as a failed test. If you are tested, assume either will register.

Is delta-10 natural?

Commercial delta-10 is made by chemically converting hemp-derived cannabinoids. Forensic chemists analysing vaping liquids have described delta-10 as an unnatural THC isomer that forms during chemical and heat treatment.⁶ Whether it counts as naturally occurring under the new federal hemp law depends on an FDA list that had not been published as of August 2026.

Are delta-8 and delta-10 legal after November 2026?

Not as hemp under federal law. Products with cannabinoids not capable of being naturally produced lose hemp status on 12 November 2026, and the total THC test and 0.4 mg per container cap apply from 11 December 2026.¹¹ Bills to delay or repeal the change are pending, and state laws vary, so check current rules where you live.

Why do people say delta-10 is energising and delta-8 is relaxing?

Those descriptions come from product marketing and user reviews. No controlled study has compared the two in people, so the difference could reflect dose, expectation, added terpenes or other cannabinoids in the product. The only firm human data concern delta-8, which produced dose-dependent intoxication similar in kind to delta-9.²

Sources

1. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol (Δ8-THC): Comparative pharmacology with Δ9-THC. Br J Pharmacol. 2022;179(15):3915-3933. DOI: 10.1111/bph.15865. PMID: 35523678. pubmed.ncbi.nlm.nih.gov
2. Zamarripa CA, Spindle TR, Schriefer D, et al.. A within-subject cross-over trial comparing the acute effects of oral delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults. Drug Alcohol Depend. 2025;272:112676. DOI: 10.1016/j.drugalcdep.2025.112676. PMID: 40288059. pubmed.ncbi.nlm.nih.gov
3. Spindle TR, Zamarripa CA, Schriefer D, et al.. A within-subject cross-over trial comparing the acute effects of vaporized delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults. Drug Alcohol Depend. 2025;272:112684. DOI: 10.1016/j.drugalcdep.2025.112684. PMID: 40334328. pubmed.ncbi.nlm.nih.gov
4. Haghdoost M, Brumar D, Geiling B, Brunstetter M, Bonn-Miller MO. Chemistry, Crystal Structure, and In Vitro Receptor Binding of Δ10-THC Isomers. Cannabis Cannabinoid Res. 2023;8(S1):S1-S10. DOI: 10.1089/can.2023.0045. PMID: 37721987. pubmed.ncbi.nlm.nih.gov
5. Wiley JL, Marusich JA, Blough BE, et al.. Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2024;132:110984. DOI: 10.1016/j.pnpbp.2024.110984. PMID: 38417478. pubmed.ncbi.nlm.nih.gov
6. Ciolino LA, Ranieri TL, Brueggemeyer JL, Taylor AM, Mohrhaus AS. EVALI Vaping Liquids Part 1: GC-MS Cannabinoids Profiles and Identification of Unnatural THC Isomers. Front Chem. 2021;9:746479. DOI: 10.3389/fchem.2021.746479. PMID: 34631667. pubmed.ncbi.nlm.nih.gov
7. Burgess A, Hays HL, Badeti J, et al.. Delta-8 tetrahydrocannabinol, delta-10 tetrahydrocannabinol, and tetrahydrocannabinol-O acetate exposures reported to America’s Poison Centers. Clin Toxicol (Phila). 2024;62(4):256-266. DOI: 10.1080/15563650.2024.2340115. PMID: 38686923. pubmed.ncbi.nlm.nih.gov
8. Meehan-Atrash J, Rahman I. Novel Δ8-Tetrahydrocannabinol Vaporizers Contain Unlabeled Adulterants, Unintended Byproducts of Chemical Synthesis, and Heavy Metals. Chem Res Toxicol. 2022;35(1):73-76. DOI: 10.1021/acs.chemrestox.1c00388. PMID: 34889611. pubmed.ncbi.nlm.nih.gov
9. Wolf CE, Pokhai AA, Poklis JL, Williams GR. The cross-reactivity of cannabinoid analogs (delta-8-THC, delta-10-THC and CBD), their metabolites and chiral carboxy HHC metabolites in urine of six commercially available homogeneous immunoassays. J Anal Toxicol. 2023;47(8):732-736. PMID: 37602947. pubmed.ncbi.nlm.nih.gov
10. U.S. Congress. Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026. Public Law 119-37 (H.R. 5371), Division B, Section 781, amending section 297A of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639o). Enacted 12 November 2025. govinfo.gov
11. U.S. Congress. Continuing Appropriations and Extensions Act, 2027. H.R. 6500 (enrolled bill), Section 2019, “Section 781 Extension”. 2026. govinfo.gov
12. Congressional Research Service. Changes to the Statutory Definition of Hemp and Implications for Agricultural Policy. In Focus IF13136. Updated August 2026. congress.gov

Editorial note: This article is for general information only and is not medical or legal advice. Delta-8 and delta-10 THC have not been evaluated by the FDA to diagnose, treat, cure or prevent any disease. Laws vary by location and change often, so verify the rules that apply where you are. Always talk to a licensed healthcare provider before use, especially if you are under 21, pregnant or nursing, taking medication, or managing a health condition.